Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma.

× No keyword cloud information.

25 in total

Review 1. Kidney cancer management in 2004: an update for the practicing general urologist.

Authors: John S Lam; Oleg Shvarts; Arie S Belldegrun
Journal: Curr Urol Rep Date: 2004-02 Impact factor: 3.092

2. New surgical horizons: the role of cytoreductive nephrectomy for metastatic kidney cancer.

Authors: Ricardo A Rendon
Journal: Can Urol Assoc J Date: 2007-06 Impact factor: 1.862

Review 3. G250: a carbonic anhydrase IX monoclonal antibody.

Authors: John S Lam; Allan J Pantuck; Arie S Belldegrun; Robert A Figlin
Journal: Curr Oncol Rep Date: 2005-03 Impact factor: 5.075

Review 4. Novel approaches in the therapy of metastatic renal cell carcinoma.

Authors: John S Lam; John T Leppert; Arie S Belldegrun; Robert A Figlin
Journal: World J Urol Date: 2005-04-05 Impact factor: 4.226

Review 5. Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma.

Authors: Mamta Parikh; Poornima Bajwa
Journal: Semin Nephrol Date: 2020-01 Impact factor: 5.299

Review 6. The Role of Nephrectomy for Kidney Cancer in the Era of Targeted and Immune Therapies.

Authors: Ulka N Vaishampayan
Journal: Am Soc Clin Oncol Educ Book Date: 2016

7. Current status of immunotherapy for the treatment of lung cancer.

Authors: Sanjay Murala; Vamsi Alli; Daniel Kreisel; Andrew E Gelman; Alexander S Krupnick
Journal: J Thorac Dis Date: 2010-12 Impact factor: 2.895

8. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.

Authors: M Horstmann; A S Merseburger; E von der Heyde; J Serth; G Wegener; M Mengel; G Feil; J Hennenlotter; U Nagele; A Anastasiadis; C Bokemeyer; A Stenzl; M Kuczyk
Journal: J Cancer Res Clin Oncol Date: 2005-11-01 Impact factor: 4.553

Review 9. Evolving immunotherapeutic strategies in bladder and renal cancer.

Authors: T R L Griffiths; J K Mellon
Journal: Postgrad Med J Date: 2004-06 Impact factor: 2.401

10. Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma.

Authors: Howard L Kaufman; Bret Taback; William Sherman; Dae Won Kim; William H Shingler; Dorota Moroziewicz; Gail DeRaffele; Josephine Mitcham; Miles W Carroll; Richard Harrop; Stuart Naylor; Seunghee Kim-Schulze
Journal: J Transl Med Date: 2009-01-07 Impact factor: 5.531